Neurogenetic contributions to amyloid beta and tau spreading in the human cortex

Tau and amyloid beta (Aβ) proteins accumulate along neuronal circuits in Alzheimer’s disease. Unraveling the genetic background for the regional vulnerability of these proteinopathies can help in understanding the mechanisms of pathology progression. To that end, we developed a novel graph theory approach and used it to investigate the intersection of longitudinal Aβ and tau positron emission tomography imaging of healthy adult individuals and the genetic transcriptome of the Allen Human Brain Atlas. We identified distinctive pathways for tau and Aβ accumulation, of which the tau pathways correlated with cognitive levels. We found that tau propagation and Aβ propagation patterns were associated with a common genetic profile related to lipid metabolism, in which APOE played a central role, whereas the tau-specific genetic profile was classified as ‘axon related’ and the Aβ profile as ‘dendrite related’. This study reveals distinct genetic profiles that may confer vulnerability to tau and Aβ in vivo propagation in the human brain.Cross-sectional and longitudinal PET imaging of amyloid beta and tau in the human brain is combined with gene expression profiles to define the interactions between Alzheimer’s disease-related pathology propagation and brain-region-specific vulnerability.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Allan R. Jones,et al.  The Allen Human Brain Atlas Comprehensive gene expression mapping of the human brain , 2012, Trends in Neurosciences.

[3]  Jorge Sepulcre,et al.  Tau positron emission tomographic imaging in aging and early Alzheimer disease , 2016, Annals of neurology.

[4]  D. Bredesen,et al.  Direct Transcriptional Effects of Apolipoprotein E , 2016, The Journal of Neuroscience.

[5]  Keith A. Johnson,et al.  In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain , 2016, The Journal of Neuroscience.

[6]  Xilin Shen,et al.  Perturbation of the Eigenvectors of the Graph Laplacian: Application to Image Denoising , 2012, ArXiv.

[7]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[8]  R. Marioni,et al.  Genetic Stratification to Identify Risk Groups for Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[9]  Keith A. Johnson,et al.  Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex , 2017, JAMA neurology.

[10]  R. Mayeux,et al.  Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease , 2013, Nature Neuroscience.

[11]  Jorge Sepulcre,et al.  Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline , 2017, Annals of neurology.

[12]  David L. Donoho,et al.  Image Manifolds which are Isometric to Euclidean Space , 2005, Journal of Mathematical Imaging and Vision.

[13]  H. Braak,et al.  PART is part of Alzheimer disease , 2015, Acta Neuropathologica.

[14]  David Warde-Farley,et al.  GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function , 2008, Genome Biology.

[15]  Margaret A. Pericak-Vance,et al.  Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias , 2014, PLoS genetics.

[16]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[17]  F. E. Grubbs.  Procedures for Detecting Outlying Observations in Samples , 1969 .

[18]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[19]  O. Hansson,et al.  Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks , 2017, Frontiers in Neuroscience.

[20]  Leslie M. Loew,et al.  Computational neurobiology is a useful tool in translational neurology: the example of ataxia , 2014, Front. Neurosci..

[21]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[22]  Gary D. Bader,et al.  Cytoscape Web: an interactive web-based network browser , 2010, Bioinform..

[23]  Min-Ying Su,et al.  Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. , 2013, Journal of Alzheimer's disease : JAD.

[24]  Reisa A. Sperling,et al.  Harvard Aging Brain Study: Dataset and accessibility , 2017, NeuroImage.

[25]  Brian J. Bacskai,et al.  Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo , 2013, Proceedings of the National Academy of Sciences.

[26]  C. Dobson,et al.  A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease , 2016, Science Advances.

[27]  Keith A. Johnson,et al.  Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β , 2017, Alzheimer's & Dementia.

[28]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[29]  Bruce R. Rosen,et al.  Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data , 2014, NeuroImage.

[30]  Keith A. Johnson,et al.  Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain , 2017, Alzheimer's & Dementia.

[31]  J. Sepulcre,et al.  In vivo staging of regional amyloid deposition , 2017, Neurology.

[32]  Eric Karran,et al.  The Cellular Phase of Alzheimer’s Disease , 2016, Cell.

[33]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[34]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[35]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[36]  Hanna Cho,et al.  In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum , 2016, Annals of neurology.

[37]  Keith A. Johnson,et al.  Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue , 2015, Annals of neurology.

[38]  Keith A. Johnson,et al.  Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly , 2016, Neurology.

[39]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[40]  Allan R. Jones,et al.  The Allen Brain Atlas: 5 years and beyond , 2009, Nature Reviews Neuroscience.

[41]  Min-Ying Su,et al.  Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. , 2014, Journal of Alzheimer's disease : JAD.

[42]  H. Braak,et al.  Vulnerability of Select Neuronal Types to Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[43]  W. Klunk,et al.  Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. , 2003, Journal of medicinal chemistry.

[44]  H. Braak,et al.  The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes , 1989, Brain Research.

[45]  David C. Van Essen,et al.  A Population-Average, Landmark- and Surface-based (PALS) atlas of human cerebral cortex , 2005, NeuroImage.

[46]  J. Trojanowski,et al.  Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.

[47]  Yukiko Matsuoka,et al.  Tissue-specific subnetworks and characteristics of publicly available human protein interaction databases , 2011, Bioinform..

[48]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[49]  Fan Zhang,et al.  Graph spectral image smoothing using the heat kernel , 2008, Pattern Recognit..

[50]  B. Hyman,et al.  Neuropathological alterations in Alzheimer disease. , 2011, Cold Spring Harbor perspectives in medicine.

[51]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[52]  Vincent Doré,et al.  In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[53]  Jee Hoon Roh,et al.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition , 2011, Nature Neuroscience.

[54]  Reisa A. Sperling,et al.  Cognitive Profile of Amyloid Burden and White Matter Hyperintensities in Cognitively Normal Older Adults , 2012, The Journal of Neuroscience.

[55]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[56]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[57]  D. V. van Essen,et al.  A Population-Average, Landmark- and Surface-based (PALS) atlas of human cerebral cortex. , 2005, NeuroImage.

[58]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[59]  Jorge Sepulcre,et al.  Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals , 2018, Nature Neuroscience.

[60]  Leon French,et al.  A FreeSurfer view of the cortical transcriptome generated from the Allen Human Brain Atlas , 2015, Front. Neurosci..

[61]  A. Fagan,et al.  ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy , 2017, Nature.

[62]  J. Haines,et al.  Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels , 2014, Alzheimer's Research & Therapy.

[63]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[64]  M. Greicius,et al.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI , 2004, Proc. Natl. Acad. Sci. USA.

[65]  A. Goate,et al.  Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis , 2015, Biological Psychiatry.

[66]  Bradford C. Dickerson,et al.  Tau PET imaging in aging and early Alzheimer's disease , 2015 .

[67]  Alex Becker,et al.  In vivo characterization of the early states of the amyloid-beta network. , 2013, Brain : a journal of neurology.

[68]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[69]  H. Arai,et al.  Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease , 2013, The Journal of Nuclear Medicine.

[70]  Keith A. Johnson,et al.  Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease , 2009, The Journal of Neuroscience.

[71]  Florence F. Roussotte,et al.  Combined Effects of Alzheimer Risk Variants in the CLU and ApoE Genes on Ventricular Expansion Patterns in the Elderly , 2014, The Journal of Neuroscience.

[72]  M. Greicius.  Resting-state functional connectivity in neuropsychiatric disorders , 2008, Current opinion in neurology.